Clinical trials
Phase 3 Optic Neuritis trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
3 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 1 |
| 2019 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 1 |
| Recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alexion Pharmaceuticals, Inc. | 1 |
| Hospices Civils de Lyon | 1 |
| MedDay Pharmaceuticals SA | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Optic Neuritis | 3 |
| Neuromyelitis Optica | 2 |
| Demyelinating Diseases | 1 |
| Multiple Sclerosis | 1 |
| Multiple Sclerosis, Chronic Progressive | 1 |
| Multiple Sclerosis, Relapsing-Remitting | 1 |
| Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease | 1 |
| Myelitis | 1 |
| Myelitis, Transverse | 1 |
| Recurrence | 1 |
Trials
Showing 1 to 3 of 3. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.